Molecular Partners AG (MOLN)
3.72
-0.16
(-4.12%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 17:24
Molecular Partners 1 Year Total Returns (Daily) : -0.13% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | -0.13% |
| June 08, 2026 | 3.97% |
| June 05, 2026 | 15.17% |
| June 04, 2026 | 7.67% |
| June 03, 2026 | 12.26% |
| June 02, 2026 | 3.43% |
| June 01, 2026 | 3.61% |
| May 29, 2026 | 17.40% |
| May 28, 2026 | -1.17% |
| May 27, 2026 | -0.49% |
| May 26, 2026 | 0.25% |
| May 22, 2026 | 7.37% |
| May 21, 2026 | -3.55% |
| May 20, 2026 | -5.08% |
| May 19, 2026 | -5.32% |
| May 18, 2026 | -1.04% |
| May 15, 2026 | -0.26% |
| May 14, 2026 | -1.79% |
| May 13, 2026 | 0.53% |
| May 12, 2026 | -5.49% |
| May 11, 2026 | 0.73% |
| May 08, 2026 | 3.42% |
| May 07, 2026 | -3.07% |
| May 06, 2026 | 5.03% |
| May 05, 2026 | 4.17% |
| Date | Value |
|---|---|
| May 04, 2026 | 8.01% |
| May 01, 2026 | 13.14% |
| April 30, 2026 | 8.46% |
| April 29, 2026 | 18.03% |
| April 28, 2026 | 4.90% |
| April 27, 2026 | 3.59% |
| April 24, 2026 | 9.31% |
| April 23, 2026 | 13.11% |
| April 22, 2026 | 11.89% |
| April 21, 2026 | 15.38% |
| April 20, 2026 | 11.08% |
| April 17, 2026 | 5.92% |
| April 16, 2026 | 17.09% |
| April 15, 2026 | 7.42% |
| April 14, 2026 | 7.25% |
| April 13, 2026 | 8.86% |
| April 10, 2026 | 14.30% |
| April 09, 2026 | 16.45% |
| April 08, 2026 | 10.70% |
| April 07, 2026 | 9.32% |
| April 06, 2026 | 13.18% |
| April 02, 2026 | 1.08% |
| April 01, 2026 | 4.30% |
| March 31, 2026 | 2.29% |
| March 30, 2026 | -13.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Kuros Biosciences Ltd. | -10.07% |
| BeOne Medicines Ltd. | 1.66% |
| AC Immune SA | 7.62% |
| CRISPR Therapeutics AG | 22.31% |
| Idorsia Ltd. | 209.1% |